Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues

Bibliography

• Myllynen P, Pasanen M, Vähäkangas K. The fate and effects of xenobiotics in human placenta. Expert Opin Drug Metab Toxicol 2007;3:331-46
   PubMed Web of Science ®Google Scholar
• Syme MR, Paxton JW, Keelan JA. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet 2004;43:487-514
   PubMed Web of Science ®Google Scholar
• Vähäkangas K, Myllynen P. Drug transporters in the human blood-placental barrier. Br J Pharmacol 2009, in press
   PubMed Web of Science ®Google Scholar
• Marin JJ, Macias RI, Briz O, Molecular bases of the fetal liver-placenta-maternal liver excretory pathway for cholephilic compounds. Liver Int 2008;28:435-54
   PubMed Web of Science ®Google Scholar
• Collier AC, Tingle MD, Paxton JW, Metabolizing enzyme localization and activities in the first trimester human placenta: the effect of maternal and gestational age, smoking and alcohol consumption. Hum Reprod 2002;17:2564-72
   PubMed Web of Science ®Google Scholar
• Collier AC, Ganley NA, Tingle MD, UDP-glucuronosyltransferase activity, expression and cellular localization in human placenta at term. Biochem Pharmacol 2002;63:409-19
   PubMed Web of Science ®Google Scholar
• Hines RN. The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol Ther 2008;118:250-67
   PubMed Web of Science ®Google Scholar
• van Kalken CK, Giaccone G, van der Valk P, Multidrug resistance gene (P-glycoprotein) expression in the human fetus. Am J Pathol 1992;141:1063-72
   PubMed Web of Science ®Google Scholar
• Daood M, Tsai C, Ahdab-Barmada M, ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS. Neuropediatrics 2008;39:211-8
   PubMed Web of Science ®Google Scholar
• Ratanasavanh D, Beaune P, Morel F, Intralobular distribution and quantitation of cytochrome P-450 enzymes in human liver as a function of age. Hepatology 1991;13:1142-51
   PubMed Web of Science ®Google Scholar
• Pelkonen O, Kärki NT. 3,4-Benzpyrene and aniline are hydroxylated by human fetal liver but not by placenta at 6-7 weeks of fetal age. Biochem Pharmacol 1973;22(12):1538-40
   PubMed Web of Science ®Google Scholar
• Omiecinski CJ, Redlich CA, Costa P. Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues: detection by the polymerase chain reaction. Cancer Res 1990;50:4315-21
   PubMed Web of Science ®Google Scholar
• Yang HY, Namkung MJ, Juchau MR. Expression of functional cytochrome P4501A1 in human embryonic hepatic tissues during organogenesis. Biochem Pharmacol 1995;49:717-26
   PubMed Web of Science ®Google Scholar
• Murray GI, Foster CO, Barnes TS, Cytochrome P450IA expression in adult and fetal human liver. Carcinogenesis 1992;13:165-9
   PubMed Web of Science ®Google Scholar
• Cresteil T, Beaune P, Kremers P, Immunoquantification of epoxide hydrolase and cytochrome P-450 isozymes in fetal and adult human liver microsomes. Eur J Biochem 1985;151:345-50
   PubMedGoogle Scholar
• Hakkola J, Pasanen M, Purkunen R, Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem Pharmacol 1994;48(1):59-64
   PubMed Web of Science ®Google Scholar
• Pasanen M. The expression and regulation of drug metabolism in human placenta. Adv Drug Deliv Rev 1999;38(1):81-97
   PubMed Web of Science ®Google Scholar
• Myllynen P, Pasanen M, Pelkonen O. Human placenta: a human organ for developmental toxicology research and biomonitoring. Placenta 2005;26:361-71
   PubMed Web of Science ®Google Scholar
• Sonnier M, Cresteil T. Delayed ontogenesis of CYP1A2 in the human liver. Eur J Biochem 1998;251:893-8
   PubMedGoogle Scholar
• Hakkola J, Raunio H, Purkunen R, Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem Pharmacol 1996;52:379-83
   PubMed Web of Science ®Google Scholar
• Hakkola J, Pasanen M, Hukkanen J, Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta. Biochem Pharmacol 1996;51:403-11
   PubMed Web of Science ®Google Scholar
• Avery ML, Meek CE, Audus KL. The presence of inducible cytochrome P450 types 1A1 and 1A2 in the BeWo cell line. Placenta 2003;24:45-52
   PubMed Web of Science ®Google Scholar
• Guengerich FP. Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 1999;39:1-17
   PubMed Web of Science ®Google Scholar
• Koukouritaki SB, Manro JR, Marsh SA, Developmental expression of human hepatic CYP2C9 and CYP2C19. J Pharmacol Exp Ther 2004;308:965-74
   PubMed Web of Science ®Google Scholar
• Ladona MG, Lindström B, Thyr C, Differential foetal development of the O- and N-demethylation of codeine and dextromethorphan in man. Br J Clin Pharmacol 1991;32:295-302
   PubMed Web of Science ®Google Scholar
• Treluyer JM, Jacqz-Aigrain E, Alvarez F, Expression of CYP2D6 in developing human liver. Eur J Biochem 1991;202:583-8
   PubMedGoogle Scholar
• McRobie DJ, Glover DD, Tracy TS. Effects of gestational and overt diabetes on human placental cytochromes P450 and glutathione S-transferase. Drug Metab Dispos 1998;26:367-71
   PubMed Web of Science ®Google Scholar
• Lacroix D, Sonnier M, Moncion A, Expression of CYP3A in the human liver–evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 1997;247:625-34
   PubMedGoogle Scholar
• Ring JA, Ghabrial H, Ching MS, Fetal hepatic drug elimination. Pharmacol Ther 1999;84:429-45
   PubMed Web of Science ®Google Scholar
• Miki Y, Suzuki T, Tazawa C, Steroid and xenobiotic receptor (SXR), cytochrome P450 3A4 and multidrug resistance gene 1 in human adult and fetal tissues. Mol Cell Endocrinol 2005;231:75-85
   PubMed Web of Science ®Google Scholar
• Vieira I, Sonnier M, Cresteil T. Developmental expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period. Eur J Biochem 1996;238:476-83
   PubMedGoogle Scholar
• Johnsrud EK, Koukouritaki SB, Divakaran K, Human hepatic CYP2E1 expression during development. J Pharmacol Exp Ther 2003;307:402-7
   PubMed Web of Science ®Google Scholar
• Carpenter SP, Lasker JM, Raucy JL. Expression, induction, and catalytic activity of the ethanol-inducible cytochrome P450 (CYP2E1) in human fetal liver and hepatocytes. Mol Pharmacol 1996;49:260-8
   PubMed Web of Science ®Google Scholar
• Boutelet-Bochan H, Huang Y, Juchau MR. Expression of CYP2E1 during embryogenesis and fetogenesis in human cephalic tissues: implications for the fetal alcohol syndrome. Biochem Biophys Res Commun 1997;238:443-7
   PubMed Web of Science ®Google Scholar
• Rasheed A, Hines RN, McCarver-May DG. Variation in induction of human placental CYP2E1: possible role in susceptibility to fetal alcohol syndrome? Toxicol Appl Pharmacol 1997;144:396-400
   PubMed Web of Science ®Google Scholar
• Richard K, Hume R, Kaptein E, Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. J Clin Endocrinol Metab 2001;86(6):2734-42
   PubMed Web of Science ®Google Scholar
• Duanmu Z, Weckle A, Koukouritaki SB, Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver. J Pharmacol Exp Ther 2006;316:1310-7
   PubMed Web of Science ®Google Scholar
• Stanley EL, Hume R, Coughtrie MW. Expression profiling of human fetal cytosolic sulfotransferases involved in steroid and thyroid hormone metabolism and in detoxification. Mol Cell Endocrinol 2005;240:32-42
   PubMed Web of Science ®Google Scholar
• Stanley EL, Hume R, Visser TJ, Differential expression of sulfotransferase enzymes involved in thyroid hormone metabolism during human placental development. J Clin Endocrinol Metab 2001;86:5944-55
   PubMed Web of Science ®Google Scholar
• Geese WJ, Raftogianis RB. Biochemical characterization and tissue distribution of human SULT2B1. Biochem Biophys Res Commun 2001;288:280-9
   PubMed Web of Science ®Google Scholar
• Garland M, Abildskov KM, Kiu TW, The contribution of fetal metabolism to the disposition of morphine. Drug Metab Dispos 2005;33:68-76
   PubMed Web of Science ®Google Scholar
• Garland M, Abildskov KM, Taylor S, Fetal morphine metabolism and clearance are constant during late gestation. Drug Metab Dispos 2006;34:636-46
   PubMed Web of Science ®Google Scholar
• Patterson TA, Binienda ZK, Lipe GW, Transplacental pharmacokinetics and fetal distribution of azidothymidine, its glucuronide, and phosphorylated metabolites in late-term rhesus macaques after maternal infusion. Drug Metab Dispos 1997;25:453-9
   PubMed Web of Science ®Google Scholar
• Collier AC, Keelan JA, Van Zijl PE, Human placental glucuronidation and transport of 3′azido-3′-deoxythymidine and uridine diphosphate glucuronic acid. Drug Metab Dispos 2004;32:813-20
   PubMed Web of Science ®Google Scholar
• Strange RC, Davis BA, Faulder CG, The human glutathione S-transferases: developmental aspects of the GST1, GST2, and GST3 loci. Biochem Genet 1985;23:1011-28
   PubMed Web of Science ®Google Scholar
• Hiley C, Bell J, Hume R, Differential expression of alpha and pi isoenzymes of glutathione S-transferase in developing human kidney. Biochim Biophys Acta 1989;990(3):321-4
   PubMed Web of Science ®Google Scholar
• Takano M, Yumoto R, Murakami T. Expression and function of efflux drug transporters in the intestine. Pharmacol Ther 2006;109:137-61
   PubMed Web of Science ®Google Scholar
• Löscher W, Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 2005;6:591-602
   PubMed Web of Science ®Google Scholar
• Kimura Y, Morita SY, Matsuo M, Mechanism of multidrug recognition by MDR1/ABCB1. Cancer Sci 2007;98:1303-10
   PubMed Web of Science ®Google Scholar
• Schumacher U, Mollgård K. The multidrug-resistance P-glycoprotein (Pgp, MDR1) is an early marker of blood-brain barrier development in the microvessels of the developing human brain. Histochem Cell Biol 1997;108:179-82
   PubMed Web of Science ®Google Scholar
• Virgintino D, Errede M, Girolamo F, Fetal blood-brain barrier P-glycoprotein contributes to brain protection during human development. J Neuropathol Exp Neurol 2008;67:50-61
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Shofuda T, Islam MO, ABCB1 is predominantly expressed in human fetal neural stem/progenitor cells at an early development stage. J Neurosci Res 2009; published online 21 April 2009, doi 10.1002/jnr.22094
   Web of Science ®Google Scholar
• Sugawara I, Kataoka I, Morishita Y, Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res 1988;48:1926-9
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C, O'Brien JP, Boccia J, Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 1990;38:1277-87
   PubMed Web of Science ®Google Scholar
• Ushigome F, Takanaga H, Matsuo H, Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein. Eur J Pharmacol 2000;408:1-10
   PubMed Web of Science ®Google Scholar
• Evseenko DA, Paxton JW, Keelan JA. Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors. Drug Metab Dispos 2007;35:595-601
   PubMed Web of Science ®Google Scholar
• Mölsä M, Heikkinen T, Hakkola J, Functional role of P-glycoprotein in the human blood-placental barrier. Clin Pharmacol Ther 2005;78:123-31
   PubMed Web of Science ®Google Scholar
• Pávek P, Fendrich Z, Staud F, Influence of P-glycoprotein on the transplacental passage of cyclosporine. J Pharm Sci 2001;90:1583-92
   PubMed Web of Science ®Google Scholar
• Lankas GR, Wise LD, Cartwright ME, Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod Toxicol 1998;12:457-63
   PubMed Web of Science ®Google Scholar
• Sun M, Kingdom J, Baczyk D, Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta 2006;27:602-9
   PubMed Web of Science ®Google Scholar
• Gil S, Saura R, Forestier F, P-glycoprotein expression of the human placenta during pregnancy. Placenta 2005;26:268-70
   PubMed Web of Science ®Google Scholar
• Mathias AA, Hitti J, Unadkat JD. P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am J Physiol Regul Integr Comp Physiol 2005;289:R963-9
   PubMed Web of Science ®Google Scholar
• Nanovskaya TN, Nekhayeva IA, Hankins GD, Transfer of methadone across the dually perfused preterm human placental lobule. Am J Obstet Gynecol 2008;198:126.e1-4
   PubMed Web of Science ®Google Scholar
• Petropoulos S, Kalabis GM, Gibb W, Functional changes of mouse placental multidrug resistance phosphoglycoprotein (ABCB1) with advancing gestation and regulation by progesterone. Reprod Sci 2007;14:321-8
   PubMed Web of Science ®Google Scholar
• Coles LD, Lee IJ, Hassan HE, Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice. J Pharm Sci 2008;98:2832-46
   Web of Science ®Google Scholar
• Tanabe M, Ieiri I, Nagata N, Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther 2001;297:1137-43
   PubMed Web of Science ®Google Scholar
• Hitzl M, Schaeffeler E, Hocher B, Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1). Pharmacogenetics 2004;14:309-18
   PubMedGoogle Scholar
• Rahi M, Heikkinen T, Hakkola J, Influence of adenosine triphosphate and ABCB1 (MDR1) genotype on the P-glycoprotein-dependent transfer of saquinavir in the dually perfused human placenta. Hum Exp Toxicol 2008;27(1):65-71
   PubMed Web of Science ®Google Scholar
• Malek A, Obrist C, Wenzinger S, The impact of cocaine and heroin on the placental transfer of methadone. Reprod Biol Endocrinol 2009;7:61
   PubMed Web of Science ®Google Scholar
• St-Pierre MV, Stallmach T, Freimoser Grundschober A, Temporal expression profiles of organic anion transport proteins in placenta and fetal liver of the rat. Am J Physiol Regul Integr Comp Physiol 2004;287:R1505-16
   PubMed Web of Science ®Google Scholar
• Chen HL, Chen HL, Liu YJ, Developmental expression of canalicular transporter genes in human liver. J Hepatol 2005;43:472-7
   PubMed Web of Science ®Google Scholar
• Takayanagi S, Kataoka T, Ohara O, Human ATP-binding cassette transporter ABCC10: expression profile and p53-dependent upregulation. J Exp Ther Oncol 2004;4:239-46
   PubMedGoogle Scholar
• Yabuuchi H, Shimizu H, Takayanagi S, Multiple splicing variants of two new human ATP-binding cassette transporters, ABCC11 and ABCC12. Biochem Biophys Res Commun 2001;288:933-9
   PubMed Web of Science ®Google Scholar
• Beck K, Dang K, Boyd CD. The tissue distribution of murine Abcc6 (Mrp6) during embryogenesis indicates that the presence of Abcc6 in elastic tissues is not required for elastic fiber assembly. J Mol Histol 2005;36:167-70
   PubMed Web of Science ®Google Scholar
• Azzaroli F, Mennone A, Feletti V, Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. Aliment Pharmacol Ther 2007;26:1139-46
   PubMed Web of Science ®Google Scholar
• Meyer Zu Schwabedissen HE, Grube M, Heydrich B, Expression, localization, and function of MRP5 (ABCC5), a transporter for cyclic nucleotides, in human placenta and cultured human trophoblasts: effects of gestational age and cellular differentiation. Am J Pathol 2005;166:39-48
   PubMed Web of Science ®Google Scholar
• Meyer zu Schwabedissen HE, Jedlitschky G, Gratz M, Variable expression of MRP2 (ABCC2) in human placenta: influence of gestational age and cellular differentiation. Drug Metab Dispos 2005;33:896-904
   PubMed Web of Science ®Google Scholar
• Nagashige M, Ushigome F, Koyabu N, Basal membrane localization of MRP1 in human placental trophoblast. Placenta 2003;24:951-8
   PubMed Web of Science ®Google Scholar
• Bergen AA, Plomp AS, Schuurman EJ, Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet 2000;25:228-31
   PubMed Web of Science ®Google Scholar
• Tammur J, Prades C, Arnould I, Two new genes from the human ATP-binding cassette transporter superfamily, ABCC11 and ABCC12, tandemly duplicated on chromosome 16q12. Gene 2001;273:89-96
   PubMed Web of Science ®Google Scholar
• Serrano MA, Macias RI, Briz O, Expression in human trophoblast and choriocarcinoma cell lines, BeWo, Jeg-3 and JAr of genes involved in the hepatobiliary-like excretory function of the placenta. Placenta 2007;28:107-17
   PubMed Web of Science ®Google Scholar
• Scheffer GL, Hu X, Pijnenborg AC, MRP6(ABCC6) detection in normal human tissues and tumors. Lab Invest 2002;82:515-8
   PubMed Web of Science ®Google Scholar
• May K, Minarikova V, Linnemann K, Role of the multidrug transporter proteins ABCB1 and ABCC2 in the diaplacental transport of talinolol in the term human placenta. Drug Metab Dispos 2008;36:740-4
   PubMed Web of Science ®Google Scholar
• St-Pierre MV, Serrano MA, Macias RI, Expression of members of the multidrug resistance protein family in human term placenta. Am J Physiol Regul Integr Comp Physiol 2000;279:R1495-503
   PubMed Web of Science ®Google Scholar
• Cygalova L, Ceckova M, Pavek P, Role of breast cancer resistance protein (Bcrp/Abcg2) in fetal protection during gestation in rat. Toxicol Lett 2008;178:176-80
   PubMed Web of Science ®Google Scholar
• Robey RW, To KK, Polgar O, ABCG2: a perspective. Adv Drug Deliv Rev 2009;61:3-13
   PubMed Web of Science ®Google Scholar
• Aye IL, Paxton JW, Evseenko DA, Expression, localisation and activity of ATP binding cassette (ABC) family of drug transporters in human amnion membranes. Placenta 2007;28(8-9):868-77
   PubMed Web of Science ®Google Scholar
• Kobayashi D, Ieiri I, Hirota T, Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta. Drug Metab Dispos 2005;33:94-101
   PubMed Web of Science ®Google Scholar
• Meyer zu Schwabedissen HE, Jedlitschky G, Variable expression of MRP2 (ABCC2) in human placenta: influence of gestational age and cellular differentiation. Drug Metab Dispos 2005;33:896-904
   PubMed Web of Science ®Google Scholar
• Yeboah D, Sun M, Kingdom J, Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor. Can J Physiol Pharmacol 2006;84:1251-8
   PubMed Web of Science ®Google Scholar
• Yasuda S, Itagaki S, Hirano T, Expression level of ABCG2 in the placenta decreases from the mid stage to the end of gestation. Biosci Biotechnol Biochem 2005;69:1871-6
   PubMed Web of Science ®Google Scholar
• Wang H, Wu X, Hudkins K, Expression of the breast cancer resistance protein (Bcrp1/Abcg2) in tissues from pregnant mice: effects of pregnancy and correlations with nuclear receptors. Am J Physiol Endocrinol Metab 2006;291:E1295-304
   PubMed Web of Science ®Google Scholar
• Mao Q. BCRP/ABCG2 in the placenta: expression, function and regulation. Pharm Res 2008;25:1244-55
   PubMed Web of Science ®Google Scholar
• Pollex E, Lubetsky A, Koren G. The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta. Placenta 2008;29:743-7
   PubMed Web of Science ®Google Scholar
• Myllynen P, Kummu M, Kangas T, ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in perfused term human placenta. Toxicol Appl Pharmacol 2008;232:210-7
   PubMed Web of Science ®Google Scholar
• Sundström E, Kölare S, Souverbie F, Neurochemical differentiation of human bulbospinal monoaminergic neurons during the first trimester. Brain Res Dev Brain Res 1993;75:1-12
   PubMedGoogle Scholar
• Gaspar P, Cases O, Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 2003;4:1002-12
   PubMed Web of Science ®Google Scholar
• Amireault P, Dubé F. Serotonin and its antidepressant-sensitive transport in mouse cumulus-oocyte complexes and early embryos. Biol Reprod 2005;73:358-65
   PubMed Web of Science ®Google Scholar
• Narboux-Nême N, Pavone LM, Avallone L, Serotonin transporter transgenic (SERTcre) mouse line reveals developmental targets of serotonin specific reuptake inhibitors (SSRIs). Neuropharmacology 2008;55:994-1005
   PubMed Web of Science ®Google Scholar
• Ren ZG, Pörzgen PP, Youn YH, Ubiquitous embryonic expression of the norepinephrine transporter. Dev Neurosci 2003;25:1-13
   PubMed Web of Science ®Google Scholar
• Balkovetz DF, Tiruppathi C, Leibach FH, Evidence for an imipramine-sensitive serotonin transporter in human placental brush-border membranes. J Biol Chem 1989;264:2195-8
   PubMed Web of Science ®Google Scholar
• Jayanthi LD, Prasad PD, Ramamoorthy S, Sodium- and chloride-dependent, cocaine-sensitive, high-affinity binding of nisoxetine to the human placental norepinephrine transporter. Biochemistry 1993;32:12178-85
   PubMed Web of Science ®Google Scholar
• Shearman LP, Meyer JS. Cocaine up-regulates norepinephrine transporter binding in the rat placenta. Eur J Pharmacol 1999;386:1-6
   PubMed Web of Science ®Google Scholar
• Koepsell H, Lips K, Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 2007;24:1227-51
   PubMed Web of Science ®Google Scholar
• Verhaagh S, Schweifer N, Barlow DP, Cloning of the mouse and human solute carrier 22a3 (Slc22a3/SLC22A3) identifies a conserved cluster of three organic cation transporters on mouse chromosome 17 and human 6q26-q27. Genomics 1999;55:209-18
   PubMed Web of Science ®Google Scholar
• Pavlova A, Sakurai H, Leclercq B, Developmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and roct. Am J Physiol Renal Physiol 2000;278:F635-43
   PubMed Web of Science ®Google Scholar
• Sweet DH, Eraly SA, Vaughn DA, Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture models. Kidney Int 2006;69:837-45
   PubMed Web of Science ®Google Scholar
• Slitt AL, Cherrington NJ, Hartley DP, Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels. Drug Metab Dispos 2002;30:212-9
   PubMed Web of Science ®Google Scholar
• Sata R, Ohtani H, Tsujimoto M, Functional analysis of organic cation transporter 3 expressed in human placenta. J Pharmacol Exp Ther 2005;315:888-95
   PubMed Web of Science ®Google Scholar
• Bottalico B, Larsson I, Brodszki J, Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies. Placenta 2004;25:518-29
   PubMed Web of Science ®Google Scholar
• Urakami Y, Akazawa M, Saito H, cDNA cloning, functional characterization, and tissue distribution of an alternatively spliced variant of organic cation transporter hOCT2 predominantly expressed in the human kidney. J Am Soc Nephrol 2002;13:1703-10
   PubMed Web of Science ®Google Scholar
• Wessler I, Roth E, Deutsch C, Release of non-neuronal acetylcholine from the isolated human placenta is mediated by organic cation transporters. Br J Pharmacol 2001;134:951-6
   PubMed Web of Science ®Google Scholar
• Grube M, Schwabedissen HM, Draber K, Expression, localization, and function of the carnitine transporter octn2 (slc22a5) in human placenta. Drug Metab Dispos 2005;33:31-7
   PubMed Web of Science ®Google Scholar
• Grigat S, Harlfinger S, Pal S, Probing the substrate specificity of the ergothioneine transporter with methimazole, hercynine, and organic cations. Biochem Pharmacol 2007;74:309-16
   PubMed Web of Science ®Google Scholar
• Tokuhiro S, Yamada R, Chang X, An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 2003;35:341-8
   PubMed Web of Science ®Google Scholar
• Gründemann D, Harlfinger S, Golz S, Discovery of the ergothioneine transporter. Proc Natl Acad Sci USA 2005;102:5256-61
   PubMed Web of Science ®Google Scholar
• Zhou SF. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 2008;38:802-32
   PubMed Web of Science ®Google Scholar
• Buist SC, Cherrington NJ, Choudhuri S, Gender-specific and developmental influences on the expression of rat organic anion transporters. J Pharmacol Exp Ther 2002;301:145-51
   PubMed Web of Science ®Google Scholar
• Cha SH, Sekine T, Kusuhara H, Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem 2000;275:4507–4512
   PubMed Web of Science ®Google Scholar
• Ugele B, St-Pierre MV, Pihusch M, Characterization and identification of steroid sulfate transporters of human placenta. Am J Physiol Endocrinol Metab 2003;284:E390-8
   PubMed Web of Science ®Google Scholar
• Hosoyamada M, Sekine T, Kanai Y, Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol 1999;276:F122-8
   PubMed Web of Science ®Google Scholar
• Hagenbuch B, Gui C. Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. Xenobiotica 2008;38:778-801
   PubMed Web of Science ®Google Scholar
• Tamai I, Nezu J, Uchino H, Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun 2000;273:251-60
   PubMed Web of Science ®Google Scholar
• Gao B, St Pierre MV, Stieger B, Differential expression of bile salt and organic anion transporters in developing rat liver. J Hepatol 2004;41:201-8
   PubMed Web of Science ®Google Scholar
• Angeletti RH, Bergwerk AJ, Novikoff PM, Dichotomous development of the organic anion transport protein in liver and choroid plexus. Am J Physiol 1998;275:C882-7
   PubMed Web of Science ®Google Scholar
• Patel P, Weerasekera N, Hitchins M, Semi quantitative expression analysis of MDR3, FIC1, BSEP, OATP-A, OATP-C, OATP-D, OATP-E and NTCP gene transcripts in 1st and 3rd trimester human placenta. Placenta 2003;24:39-44
   PubMed Web of Science ®Google Scholar
• St-Pierre MV, Hagenbuch B, Ugele B, Characterization of an organic anion-transporting polypeptide (OATP-B) in human placenta. J Clin Endocrinol Metab 2002;87:1856-63
   PubMed Web of Science ®Google Scholar
• Sato K, Sugawara J, Sato T, Expression of organic anion transporting polypeptide E (OATP-E) in human placenta. Placenta 2003;24:144-8
   PubMed Web of Science ®Google Scholar
• Miller RK, Faber W, Asai M, The role of the human placenta in embryonic nutrition. Impact of environmental and social factors. Ann NY Acad Sci 1993;678:92-107
   PubMed Web of Science ®Google Scholar
• Rizwan AN, Burckhardt G. Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles. Pharm Res 2007;24:450-70
   PubMed Web of Science ®Google Scholar
• Cheng X, Klaassen CD. Tissue distribution, ontogeny, and hormonal regulation of xenobiotic transporters in mouse kidneys. Drug Metab Dispos 2009. [Epub ahead of print]
   Web of Science ®Google Scholar
• Kiefer JC. Epigenetics in development. Dev Dyn 2007;236:1144-56
   PubMed Web of Science ®Google Scholar
• Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007;447(7143):425-32
   PubMed Web of Science ®Google Scholar
• Cui YJ, Yeager RL, Zhong XB, Ontogenic expression of hepatic Ahr mRNA is associated with histone H3K4 di-methylation during mouse liver development. Toxicol Lett 2009;189:184-90
   Google Scholar
• Li Y, Cui Y, Hart SN, Dynamic patterns of histone methylation are associated with ontogenic expression of the Cyp3a genes during mouse liver maturation. Mol Pharmacol 2009;75:1171-9
   PubMed Web of Science ®Google Scholar
• To KK, Polgar O, Huff LM, Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells. Mol Cancer Res 2008;6(1):151-64
   PubMed Web of Science ®Google Scholar
• Calcagno AM, Fostel JM, To KK, Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes. Br J Cancer 2008;98:1515-24
   PubMed Web of Science ®Google Scholar
• Novakovic B, Sibson M, Ng HK, Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. J Biol Chem 2009;284:14838-48
   PubMed Web of Science ®Google Scholar
• Atkinson DE, Brice-Bennett S, D'Souza SW. Antiepileptic medication during pregnancy: does fetal genotype affect outcome? Pediatr Res 2007;62:120-7
   PubMed Web of Science ®Google Scholar
• Petrovic V, Wang JH, Piquette-Miller M. Effect of endotoxin on the expression of placental drug transporters and glyburide disposition in pregnant rats. Drug Metab Dispos 2008;36:1944-50
   PubMed Web of Science ®Google Scholar
• Pasanen M, Helin-Martikainen HL, Pelkonen O, Intrahepatic cholestasis of pregnancy impairs the activities of human placental xenobiotic and steroid metabolizing enzymes in vitro. Placenta 1997;18:37-41
   PubMed Web of Science ®Google Scholar
• Bièche I, Narjoz C, Asselah T, Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1,CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics 2007;17:731-42
   PubMed Web of Science ®Google Scholar
• Lee QH, Fantel AG, Juchau MR. Human embryonic cytochrome P450S: phenoxazone ethers as probes for expression of functional isoforms during organogenesis. Biochem Pharmacol 1991;42:2377-85
   PubMed Web of Science ®Google Scholar
• Cazeneuve C, Pons G, Rey E, Biotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults. Br J Clin Pharmacol 1994;37:405-12
   PubMed Web of Science ®Google Scholar
• Wrighton SA, Brian WR, Sari MA et al. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 HLp3. Mol Pharmacol 1990;38:207-13
   PubMed Web of Science ®Google Scholar
• Ratcliffe J, Nakanishi M, Jaffe RB. Identification of definitive and fetal zone markers in the human fetal adrenal gland reveals putative developmental genes. J Clin Endocrinol Metab 2003;88:3272-7
   PubMed Web of Science ®Google Scholar
• Islam MO, Kanemura Y, Tajria J, Characterization of ABC transporter ABCB1 expressed in human neural stem/progenitor cells. FEBS Lett 2005;579:3473-80
   PubMed Web of Science ®Google Scholar
• Gorelik J, Patel P, Ng'andwe C, Genes encoding bile acid, phospholipid and anion transporters are expressed in a human fetal cardiomyocyte culture. BJOG 2006;113:552-8
   PubMed Web of Science ®Google Scholar
• Pascolo L, Fernetti C, Pirulli D, Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in BeWo cells. Biochem Biophys Res Commun 2003;303:259-65
   PubMed Web of Science ®Google Scholar
• Ramamoorthy JD, Ramamoorthy S, Leibach FH, Human placental monoamine transporters as targets for amphetamines. Am J Obstet Gynecol 1995;173:1782-7
   PubMed Web of Science ®Google Scholar
• Lubec B, Yoo BC, Dierssen M, Down syndrome patients start early prenatal life with normal cholinergic, monoaminergic and serotoninergic innervations. J Neural Transm Suppl 2001;61:303-10
   PubMedGoogle Scholar
• Ramamoorthy S, Leibach FH, Mahesh VB, Partial purification and characterization of the human placental serotonin transporter. Placenta 1993;14:449-61
   PubMed Web of Science ®Google Scholar
• Prasad PD, Hoffmans BJ, Moe AJ, Functional expression of the plasma membrane serotonin transporter but not the vesicular monoamine transporter in human placental trophoblasts and choriocarcinoma cells. Placenta 1996;17:201-7
   PubMed Web of Science ®Google Scholar
• Brocco M, Dekeyne A, Veiga S, Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents. Pharmacol Biochem Behav 2002;71:667-80
   PubMed Web of Science ®Google Scholar
• Rothman RB, Baumann MH. Therapeutic and adverse actions of serotonin transporter substrates. Pharmacol Ther 2000;95:73-88
   Web of Science ®Google Scholar
• Schwartz JW, Novarino G, Piston DW, Substrate binding stoichiometry and kinetics of the norepinephrine transporter. J Biol Chem 2005;280:19177-84
   PubMed Web of Science ®Google Scholar
• Khamdang S, Takeda M, Noshiro R, Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 2002;303:534-9
   PubMed Web of Science ®Google Scholar
• Minuesa G, Volk C, Molina-Arcas M, Transport of lamivudine [(-)-beta-L-2′,3′-dideoxy-3′-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3. J Pharmacol Exp Ther 2009;329:252-61
   PubMed Web of Science ®Google Scholar
• Bourdet DL, Pritchard JB, Thakker DR. Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3). J Pharmacol Exp Ther 2005;315:1288-97
   PubMed Web of Science ®Google Scholar